Increased accumulation of renal sorbitol has been documented in the diabetic rat, and it has been suggested that this accumulation may be important in the pathogenesis of diabetic nephropathy. It is not clear whether sorbitol accumulation results from increases in substrate, activity of the aldose reductase (AR) protein molecule, or activity due to an increase in the amount of enzyme present. In this study, we have quantitated renal AR activity, immunoreactivity, and mRNA in rats 3 mo after induction of diabetes with streptozocin (STZ-D, 65 mg/kg body wt). Renal AR activity was significantly increased in diabetic rats compared with age-matched nondiabetic controls (0.95 ± 0.05 vs. 0.51 ± 0.03 U m g 1 h~1, respectively, P < .0005). Western blot analysis demonstrated that the antiserums recognized a single 40,000-M r protein species in renal homogenates from both diabetic and nondiabetic rats. When quantitated in an immunodot assay, AR immunoreactivity was significantly increased in diabetic rats compared with nondiabetic controls (0.57 ± 0.03 vs. 0.33 ± 0.02 U, respectively, P < .0005). Hybridization of Northern blots with a synthetic 36-nucleotide oligomer and an AR cDNA identified a 1.4-kilobase pair transcript; the abundance of the transcript was significantly increased in poly(A) + RNA from the kidneys of diabetic compared with nondiabetic rats (P < .005). This study demonstrates that renal AR activity is increased in the STZ-D rats and suggests that the increased AR activity can be in part explained by enhanced AR gene expression.
Increased accumulation of renal sorbitol has been documented in the diabetic rat, and it has been suggested that this accumulation may be important in the pathogenesis of diabetic nephropathy. It is not clear whether sorbitol accumulation results from increases in substrate, activity of the aldose reductase (AR) protein molecule, or activity due to an increase in the amount of enzyme present. In this study, we have quantitated renal AR activity, immunoreactivity, and mRNA in rats 3 mo after induction of diabetes with streptozocin (STZ-D, 65 mg/kg body wt). Renal AR activity was significantly increased in diabetic rats compared with age-matched nondiabetic controls (0.95 ± 0.05 vs. 0.51 ± 0.03 U m g 1 h~1, respectively, P < .0005). Western blot analysis demonstrated that the antiserums recognized a single 40,000-M r protein species in renal homogenates from both diabetic and nondiabetic rats. When quantitated in an immunodot assay, AR immunoreactivity was significantly increased in diabetic rats compared with nondiabetic controls (0.57 ± 0.03 vs. 0.33 ± 0.02 U, respectively, P < .0005). Hybridization of Northern blots with a synthetic 36-nucleotide oligomer and an AR cDNA identified a 1.4-kilobase pair transcript; the abundance of the transcript was significantly increased in poly(A) + RNA from the kidneys of diabetic compared with nondiabetic rats (P < .005). This study demonstrates that renal AR activity is increased in the STZ-D rats and suggests that the increased AR activity can be in part explained by enhanced AR gene expression. Diabetes 38:1067-71, 1989 A ldose reductase (AR), a rate-limiting enzyme in the polyol pathway, is a member of the monomer NADPH-dependent aldo-keto reductases. It catalyzes the reduction of various aldehydes, including the aldehyde form of glucose to its corresponding sugar alcohol sorbitol (1) . Accumulation of sorbitol has been reported in the lens, nerve, kidney, and retina of diabetic animals (2) (3) (4) (5) . Glucose transport in these tissues is thought to be relatively insulin independent, and therefore they are exposed to the large increases in plasma glucose that occur in diabetic animals (6) . Accumulation of sorbitol causes osmotic disruption, which appears to be one of the etiologic factors in the pathogenesis of some diabetic complications. A more recent report questions the role of polyol accumulation and implicates oxidative damage as a result of competition between AR and glutathione reductase for NADPH in diabetic complications (7) .
The role of AR in the formation of diabetic cataracts, retinopathy, and peripheral neuropathy has been widely investigated (4, 8) . However, AR activity in diabetic kidney disease has attracted less attention. Mathur and Grimshaw (9) have shown, with rabbit antiserums raised against bovine kidney AR, that the rat kidney possesses a higher level of AR immunoreactivity than the heart, brain, lens, or erythrocytes. It has recently been reported that glomerular sorbitol content is increased in streptozocin-induced diabetic (STZ-D) rats (5) . Furthermore, AR inhibitors reduce microproteinuria in diabetic rats, supporting the concept that sorbitol accumulation is important in diabetic nephropathy (10) . However, the effects of diabetes on renal AR have not been reported, and it is not clear from previous studies whether increased renal sorbitol in diabetic animals is the result of increases in substrate, AR activity, or AR protein. In this study, we quantitated AR activity, immunoreactivity, and mRNA in the kidney of normal and STZ-D rats.
RESEARCH DESIGN AND METHODS
Adult female Sprague-Dawley rats 60-65 days of age were obtained from the University of Manitoba breeding facility (Winnipeg, Manitoba, Canada). Diabetes was induced in female rats by a single injection of STZ (65 mg/kg body wt i.p.) after an overnight fast. Control rats were treated in an identical fashion but received an equivalent volume of vehicle only (citrate-buffered saline, pH 4.0). Rats were killed 3 mo after treatment. Ten of 14 surviving STZ-administered rats had serum glucose levels between 28 and 50 mM and were used in this study. A group of 10 age-matched control rats were also studied. An adult male rat of the same strain was used to prepare a testicular extract for AR immunoreactivity.
AR activity was measured according to the procedure of Gabbay and Kinoshita (11) with slight modifications. Rat tissues were homogenized in 3 vol of cold 5 mM Tris-HCI (pH 7.4) with a polytron homogenizer. After centrifugation at 45,000 x g for 40 min, enzyme activity was measured spectrophotometrically at 340 nm with DL-glyceraldehyde (Sigma, St. Louis, MO) as substrate. AR activity was determined by the loss of NADPH absorbancy within the first 2 min after initiation of the reaction. AR activity was expressed as units per milligram protein per hour, where one unit of activity was defined as the amount of enzyme that caused oxidation of 1 |xmol NADPH/min. Protein was measured by the Bradford method with bovine serum albumin as a standard (12) . AR immunoreactivity. For Western blot analysis, samples of centrifuged homogenate (40 |xg protein) were prepared, diluted in sample buffer, and electrophoresed in 10% sodium dodecyl sulfate-polyacrylamide gels according to the procedure of Laemmli (13) . Duplicate gels were either stained with Coomassie blue or transferred to nitrocellulose. Nonspecific proteins were blocked by incubation with 5% skim milk, and nitrocellulose filters were subsequently reacted with a 1:100 dilution of rabbit antiserum raised against rat testes AR in Tris-buffered saline (pH 8.0) containing 0.02% Tween 20 (14) . After appropriate washing to remove nonspecific binding, the primary antibody was revealed by incubation with anti-IgG alkaline phosphatase conjugate (BioRad, Richmond, CA) and alkaline phosphatase substrate (Promega, Mississauga, Ontario, Canada).
For immunodot analysis, individual rat samples of kidney homogenates were applied in serial dilutions (20, 5, 1, and 0.2 |ig protein in 200 \x\ 5 mM Tris-HCI, pH 7.4) to nitrocellulose with a 96-well manifold (Schleicher & Schuell, Keene, NH). All samples were analyzed in one assay. Serial dilutions of a partially purified preparation of rat testes AR were also included (14) . Nitrocellulose filters were processed as described above. The initial slope of the line of best fit for the relationship between optical density area (determined by densitometry) and protein concentration for individual rat samples was compared with the slope of the AR standard, arbitrarily attributed a value of one. The mean value obtained Autoradiography was achieved by exposing the filter to Kodak X-Omat AR film at -70°C in the presence of an enhancing screen for 24 h. The size of the AR transcript was determined by comparison with the migration of the 28S and 18S ribosomal RNAs visualized by ethidium bromide staining.
RESULTS
Body weight, serum glucose, and protein content of renal homogenates from diabetic and nondiabetic rats were com- pared (Table 1) . Significant growth retardation, reflected by the difference in body weight, and hyperglycemia were apparent in diabetic rats compared with their age-matched controls. When expressed per gram of wet weight, the protein content of renal homogenates was not significantly different in diabetic and nondiabetic rats. Renal AR activity was increased approximately twofold in diabetic versus nondiabetic rats (0.950 ± 0.051 vs. 0.510 ± 0.032 U • mg- 1 • h~\ respectively, P < .0005; Fig. 1 ).
NON-DIABETIC DIABETIC
The antitestes AR antiserums used recognized a single 40,000-M r protein species in renal homogenates and extracts of other rat tissues (Fig. 2A) . The relative abundance of this protein in the various tissues was lens > testes > kidney > adrenal gland > lung > spleen > brain > liver. The abundance of this protein was increased in renal homogenates prepared from diabetic versus nondiabetic rats (Fig. 2B) . With an immunodot assay, AR immunoreactivity was determined in renal homogenates from individual rats (Fig. 3A) . The abundance of this protein was significantly increased in renal homogenates prepared from diabetic versus nondiabetic rats (0.57 ± 0.03 vs. 0.33 ± 0.02 U, respectively, P < .0005; Fig. 3S ).
The synthetic oligomer, when used as a hybridization probe, recognized a transcript whose apparent size (1.4 kilobase pairs; Fig. 4 ) was identical to that previously reported for AR in rat tissues (21) . The AR mRNA was barely detectable in poly(A) + RNA from nondiabetic rat kidneys but was easily detectable in RNA prepared from diabetic rats. With the rat lens AR cDNA as a hybridization probe, it was possible to detect AR mRNA in nondiabetic rats and demonstrate that renal AR mRNA abundance was significantly increased in diabetic rats (Fig. 5) . 
DISCUSSION
In the presence of elevated glucose levels and a relative lack of insulin, glucose is converted into sorbitol via the polyol pathway. Accumulation of sorbitol has been demonstrated in many tissues of diabetic animals, including the kidney (22) . AR is an important rate-determining enzyme in the polyol pathway, and inhibition of this enzyme with various agents (AR inhibitors) prevents accumulation of tissue sorbitol. The usefulness of AR inhibitors in the prevention and treatment of diabetic complications is still under investigation. However, these agents reverse some of the objective changes, including impaired nerve conduction velocity and abnormal nerve structure (23) and microalbuminurea (10) , seen in diabetic rats and human diabetic subjects.
Increased sorbitol accumulation in tissues from diabetic animals may reflect increased substrate availability, diminished sorbitol dehydrogenase, and/or enhanced activity of the polyol pathway enzymes as a result of hyperglycemia or insulin deficiency. Although many investigators have interpreted increased tissue sorbitol to indicate enhanced AR activity, there are no convincing data demonstrating that AR activity is increased in diabetic tissues. Our observations clearly demonstrate that renal AR activity is increased in chronic STZ-D in the rat.
Previous studies of human tissue exposed to high glucose concentrations in vitro have suggested that there may be some alteration in the AR enzyme itself. Lorenzi et al. (24) found that human endothelial cells exposed to high glucose became progressively less sensitive to the AR inhibitor sorbinil in inhibition of sorbitol formation. These observations were interpreted as support for the earlier observations of Das and Srivastava (25) that high glucose may result in "activation" AR. They have shown that in human tissues chronically exposed to high glucose AR changes its kinetic properties and becomes less sensitive to inhibition by various agents. These observations would be difficult to explain by a simple increase in the number of enzyme molecules per cell and suggest that there may be some fundamental change in the enzymatic activity of the AR protein as a consequence of hyperglycemia. In contrast, our data suggest that the increase in AR activity in the kidneys of STZ-D rats can be explained, at least in part, by an increase in AR protein. The increase in AR immunoreactivity seen in kidney homogenates from diabetic rats cannot be explained by alteration in renal protein content of diabetic versus nondiabetic rats because this parameter did not differ significantly in the two groups of rats. It is also unlikely that increased AR activity and immunoreactivity in the kidneys of diabetic rats result from increased contamination with erythrocyte AR because this would not be accompanied by an increase in AR mRNA levels.
Our observations demonstrate that renal AR activity is increased in STZ-D rats, and the increased AR activity may in part be explained by enhanced AR gene expression. Further studies are necessary to determine the mechanism(s) by which hyperglycemia and/or insulin deficiency result in increased expression of AR.
